Your browser doesn't support javascript.
loading
FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy.
Roncato, Rossana; Dal Cin, Lisa; Mezzalira, Silvia; Comello, Francesco; De Mattia, Elena; Bignucolo, Alessia; Giollo, Lorenzo; D'Errico, Simone; Gulotta, Antonio; Emili, Luca; Carbone, Vincenzo; Guardascione, Michela; Foltran, Luisa; Toffoli, Giuseppe; Cecchin, Erika.
Affiliation
  • Roncato R; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. rroncato@cro.it.
  • Dal Cin L; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. lisa.dalcin@cro.it.
  • Mezzalira S; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. silvia.mezzalira@cro.it.
  • Comello F; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. francesco.comello@cro.it.
  • De Mattia E; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. edemattia@cro.it.
  • Bignucolo A; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. alessia.bignucolo@cro.it.
  • Giollo L; GPI, Società per Azioni (SpA), 38123 Trento, Italy. lorenzo.giollo@gpi.it.
  • D'Errico S; GPI, Società per Azioni (SpA), 38123 Trento, Italy. simone.derrico@gpi.it.
  • Gulotta A; GPI, Società per Azioni (SpA), 38123 Trento, Italy. antonio.gulotta@gpi.it.
  • Emili L; InSilicoTrials Technologies società a responsabilità limitata (s.r.l.), 34148 Trieste, Italy. luca.emili@insilicotrials.com.
  • Carbone V; InSilicoTrials Technologies società a responsabilità limitata (s.r.l.), 34148 Trieste, Italy. vincenzo.carbone@insilicotrials.com.
  • Guardascione M; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. michela.guardascione@cro.it.
  • Foltran L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCSS, 33081 Aviano, Italy. luisa.foltran@cro.it.
  • Toffoli G; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. gtoffoli@cro.it.
  • Cecchin E; Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy. ececchin@cro.it.
Genes (Basel) ; 10(4)2019 04 04.
Article de En | MEDLINE | ID: mdl-30987397
ABSTRACT
Pharmacogenetic (PGx) guidelines for the precise dosing and selection of drugs remain poorly implemented in current clinical practice. Among the barriers to the implementation process is the lack of clinical decision support system (CDSS) tools to aid health providers in managing PGx information in the clinical context. The present study aimed to describe the first Italian endeavor to develop a PGx CDSS, called FARMAPRICE. FARMAPRICE prototype was conceived for integration of patient molecular data into the clinical prescription process in the Italian Centro di Riferimento Oncologico (CRO)-Aviano Hospital. It was developed through a coordinated partnership between two high-tech companies active in the computerization of the Italian healthcare system. Introducing FARMAPRICE into the clinical setting can aid physicians in prescribing the most efficacious and cost-effective pharmacological therapy available.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ordonnances médicamenteuses / Systèmes d'aide à la décision clinique / Variants pharmacogénomiques Type d'étude: Guideline / Health_economic_evaluation / Prognostic_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Genes (Basel) Année: 2019 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ordonnances médicamenteuses / Systèmes d'aide à la décision clinique / Variants pharmacogénomiques Type d'étude: Guideline / Health_economic_evaluation / Prognostic_studies Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Genes (Basel) Année: 2019 Type de document: Article Pays d'affiliation: Italie
...